COMMUNIQUÉS West-GlobeNewswire

-
Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders
11/06/2025 -
uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer
11/06/2025 -
Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders
11/06/2025 -
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
11/06/2025 -
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
11/06/2025 -
Elkedonia clôture un tour d’amorçage de 11 millions d’euros pour le développement de neuroplastogènes comme traitements novateurs contre la dépression et les troubles neuropsychiatriques
11/06/2025 -
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders
11/06/2025 -
Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders
11/06/2025 -
Vivoryon Therapeutics N.V. to Report Q1 2025 Financial Results and Operational Progress on June 17, 2025
11/06/2025 -
CROSSJECT avance sur le développement de ZEPIZURE® Junior, sa solution pour les crises d'épilepsie chez l'enfant
11/06/2025 -
CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children
11/06/2025 -
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
11/06/2025 -
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies
11/06/2025 -
Persica strengthens global IP portfolio with EU patent granted for PP353
11/06/2025 -
Telescope Innovations’ Directors Establish Private Debt Instrument to Accelerate Development of Self-Driving Labs
11/06/2025 -
BrightSpring Announces Pricing of Secondary Offering of Common Stock
11/06/2025 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
10/06/2025 -
Voting Rights and Shares Capital of the Company
10/06/2025 -
Celularity Announces Chief Financial Officer Transition
10/06/2025
Pages